← All stocks

FATE THERAPEUTICS INC

FATE Net selling

CIK 0001434316 #3595 in the set updated 19 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$322.90K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$322.90K

6 of 6 sales

Net

−$322.90K

−$322.90K against sales at will

By person

7 insiders · 10 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Valamehr Bahram

President and CEO

—

$168.14K (3)

−$168.14K

591,815

0.4939%

$1.46M

+65.3%

TAHL CINDY

See Remarks

—

$154.76K (3)

−$154.76K

589,355

0.4919%

$1.45M

+72.1%

Redmile Group, LLC entity

Director

—

12,884,277

10.75%

$31.69M

+0.7%

Bressi Jerome Charles

See Remarks

—

335,203

0.2798%

$824.53K

+21.4%

Adawi Kamal

Chief Financial Officer

—

100,000

0.0835%

$245.98K

—

EPSTEIN ROBERT S

Director

—

36,331

0.0303%

$89.37K

+220.6%

RASTETTER WILLIAM H

Director

—

36,331

0.0303%

$89.37K

+220.6%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 23

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 18,706,912

History held since 28 Nov 2016